Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

32.06
Delayed Data
As of Jan 17
 -0.46 / -1.41%
Today’s Change
28.25
Today|||52-Week Range
37.39
-1.29%
Year-to-Date
Pfizer warns of 'big challenge' ahead from strong dollar
5:47am / FT.com - Paid Partner Content
Why Bristol-Myers Squibb May Be a Merger Target Soon
Jan 17 / TheStreet.com - Paid Partner Content
Drug companies pledge to improve emerging markets cancer care
12:14am / FT.com - Paid Partner Content
One Simple Step to Building a Smarter Portfolio
Jan 17 / MotleyFool.com - Paid Partner Content
Gillespie Robinson & Grimm Inc Buys Apple Inc, LKQ Corp, C.R. ...
Jan 17 / GuruFocus News - Paid Partner Content
Why The Stock Market Has Soared (And We'll All Soon Know What It's Like To Be A Madof...
Jan 15 / Investing Channel - Paid Partner Content
Pfizer Continues to Fade -- Get Ready to Buy on the Dip
Jan 17 / TheStreet.com - Paid Partner Content
Drugmakers alarmed by Trump pricing threat
Jan 14 / FT.com - Paid Partner Content
Should Pfizer, Inc. Be on Your Stock Watchlist?
Jan 17 / MotleyFool.com - Paid Partner Content
Univest Corp Of Pennsylvania Buys BB&T Corp, Harris Corp, AMETEK Inc, Sells Wells Far...
Jan 13 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close32.52
Today’s open32.35
Day’s range31.78 - 32.38
Volume32,104,523
Average volume (3 months)24,640,792
Market cap$194.6B
Dividend yield3.99%
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+9.99%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)-1.52%
P/E ratio32.1
Price/Sales4.13
Price/Book3.06

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.86-1.38%
NVSNovartis-0.41-0.57%
SNYSanofi-0.51-1.23%
ABBVAbbVie-0.13-0.21%
Data as of 01/17/2017

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.51
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs